세계의 스피킹 밸브 시장 예측(-2029년) : 소재별, 용도별, 최종사용자별, 지역별

The speaking valves market is valued at an estimated USD 94 million in 2024 and is projected to reach USD 128 million by 2029 at a CAGR of 6.4% during the forecast period. With increase in tracheostomy and laryngectomy surgeries the speaking valves market is expected to grow as speaking valve is placed on patients finding it difficult to communicate after these surgeries, so speaking valve helps in bring back the speech and facilitating communication. By facilitating communication, it makes great positive impact on mental health which helps in fast recovery. Additionally, government and private players continuously trying to raise awareness and knowledge about speaking valves and ensuring that they are readily available to the people who need them. Such initiatives are expected to increase the use of speaking valves in the coming years.

"Silicone segment accounted for the highest growth rate in the speaking valves market, during the forecast period."

Based on Material, the speaking valves market is bifurcated into silicone, PVC and other materials. The silicone segment in the speaking valves market is experiencing substantial growth. Silicone speaking valves are the preferred choice because of their biocompatibility. They offer comfort, safety, durability, and hygienic properties, making them a reliable option for patients.

The tracheostomy patient experience extreme discomfort In order to cater to this need, there are medical devices such as speaking valves which provide comfort to the patients due to its material. Silicone speaking valves are biocompatible, hence compatible with the human tissue, thereby reducing adverse body reactions and ensuring safety in case of extended exposure to sensitive parts of the body. Silicone can withstand extreme temperatures and endure exposure to chemicals without degradation, thus being reliable under numerous conditions. Not to forget, its unparalleled flexibility allows silicone to produce precisely molded valves to meet individual needs, proving them to be the best available product in the market.

"Hospitals segment is expected to have the fastest growth rate in the speaking valves market, by end user, during the forecast period."

The speaking valves market is segmented into hospitals, ambulatory surgical centers and other end users, based on end user. Hospitals segment is expected to account for the highest CAGR during the forecast period. This growth can be attributed to factors like the high preference for hospital-based treatment, increasing investments in healthcare infrastructure, and the presence of the specialized expertise required for placement of speaking valves. These factors can account for the growth of this segment.

"Asia Pacific: The fastest-growing region in speaking valves market."

The worldwide market for speaking valves is categorized into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is projected to experience the most substantial growth in the forecast period. In Asia Pacific region, there is a significant increase in chronic illnesses like respiratory problems, cancer, and neurological disorders in the area, leading to a higher demand for tracheostomies resulting in increased market for speaking valves. Moreover, governments in the region are making substantial investments in healthcare infrastructure and technology and in countries like India government is providing favourable reimbursement to boost facilitate access to healthcare. This confluence of factors is propelling the speaking valves market within the Asia Pacific region.

The break-up of the profile of primary participants in the speaking valves market:

• By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30%
• By Designation: C-level - 27%, D-level - 18%, and Others - 55%
• By Region: North America - 51%, Europe - 21%, Asia Pacific - 18%, Latin America - 6%, and Middle East & Africa- 4%

The key players in this market are Coloplast A/S (Denmark), Freudenberg Group (Germany), Passy-Muir, Inc. (USA), Primed Halberstadt Medizintechnik GmbH (Germany), Medtronic (Ireland), Teleflex Incorporated (US), Andreas Fahl Medizintechnik-Vertrieb GmbH (Germany), Pepper Medical (US), Boston Medical Products Inc. (US), Parburch Medical Developments Ltd. (England), Besmed Health Business Corp (Taiwan), E. Benson Hood Laboratories, Inc. (US), The Airway Company (US), Prunus Medical (China), Mednom (South Africa), Insight Medical Products Ltd (UK), Ashton India Private Limited (India).

Research Coverage:

This research report categorizes the speaking valves market by material (Silicone, PVC and other materials), by application (tracheostomy, laryngectomy and other applications), by end user (hospitals, ambulatory surgical centers and other end users), and region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, opportunities, and challenges influencing the growth of the speaking valves market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, key strategies, acquisitions, and agreements. New product & service launches, and recent developments associated with the speaking valves market. Competitive analysis of upcoming startups in the speaking valves market ecosystem is covered in this report.

Reasons to buy this report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall speaking valves market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

• Analysis of key drivers (increasing number of tracheostomy and laryngectomy procedures, technological advancements, Favourable reimbursement scenario and the rising patient demand for ICUs and ambulatory care), opportunities (Emerging markets), restraints (High cost of tracheostomy procedure), and challenges (lack of awareness about speaking valves, and dearth of skilled surgeon) influencing the growth of the speaking valves market.
• Product Development/Innovation: Detailed insights research & development activities, and new product launches in the speaking valves market.
• Market Development: Comprehensive information about lucrative markets - the report analyses the speaking valves market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the speaking valves market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings of leading players like Coloplast A/S (Denmark), Freudenberg Group (Germany), Passy-Muir, Inc. (USA), Primed Halberstadt Medizintechnik GmbH (Germany), and Medtronic (Ireland).

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
  • 1.2.1 INCLUSIONS & EXCLUSIONS
• 1.3 MARKETS COVERED
  • 1.3.1 YEARS CONSIDERED
• 1.4 CURRENCY CONSIDERED
• 1.5 STUDY LIMITATIONS
• 1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
• 2.2 RESEARCH APPROACH
  • 2.2.1 SECONDARY DATA
    • 2.2.1.1 Key data from secondary sources
  • 2.2.2 PRIMARY DATA
    • 2.2.2.1 Primary sources
    • 2.2.2.2 Key data from primary sources
    • 2.2.2.3 Key industry insights
    • 2.2.2.4 Breakdown of primary interviews
• 2.3 MARKET SIZE ESTIMATION
  • 2.3.1 BOTTOM-UP APPROACH
    • 2.3.1.1 Approach 1: Company revenue estimation approach
    • 2.3.1.2 Approach 2: Presentations of companies and primary interviews
    • 2.3.1.3 Growth forecast
    • 2.3.1.4 CAGR projections
  • 2.3.2 TOP-DOWN APPROACH
• 2.4 MARKET BREAKDOWN & DATA TRIANGULATION
• 2.5 MARKET SHARE ANALYSIS
• 2.6 STUDY ASSUMPTIONS
• 2.7 RISK ASSESSMENT
  • 2.7.1 RISK ASSESSMENT: SPEAKING VALVES MARKET

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 SPEAKING VALVES MARKET OVERVIEW
• 4.2 SPEAKING VALVES MARKET SHARE, BY MATERIAL, 2024 VS. 2029
• 4.3 SPEAKING VALVES MARKET SHARE, BY APPLICATION, 2024 VS. 2029
• 4.4 SPEAKING VALVES MARKET SHARE, BY END USER, 2024 VS. 2029
• 4.5 SPEAKING VALVES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Increasing number of tracheostomy and laryngectomy procedures
    • 5.2.1.2 Technological advancements
    • 5.2.1.3 Favorable reimbursement scenario
    • 5.2.1.4 Rising patient demand for ICUs and ambulatory care
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 High cost of tracheostomy procedures
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Emerging markets
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Lack of awareness in emerging countries
    • 5.2.4.2 Dearth of skilled surgeons
• 5.3 PRICING ANALYSIS
  • 5.3.1 AVERAGE SELLING PRICE OF SPEAKING VALVES, BY REGION
• 5.4 PATENT ANALYSIS
  • 5.4.1 LIST OF MAJOR PATENTS
• 5.5 VALUE CHAIN ANALYSIS
• 5.6 SUPPLY CHAIN ANALYSIS
• 5.7 TRADE ANALYSIS
  • 5.7.1 TRADE ANALYSIS
• 5.8 ECOSYSTEM ANALYSIS
• 5.9 PORTER'S FIVE FORCES ANALYSIS
  • 5.9.1 THREAT OF NEW ENTRANTS
  • 5.9.2 THREAT OF SUBSTITUTES
  • 5.9.3 BARGAINING POWER OF BUYERS
  • 5.9.4 BARGAINING POWER OF SUPPLIERS
  • 5.9.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.10 REGULATORY LANDSCAPE
  • 5.10.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.10.2 REGULATORY SCENARIO
    • 5.10.2.1 North America
      • 5.10.2.1.1 US
      • 5.10.2.1.2 Canada
    • 5.10.2.2 Europe
    • 5.10.2.3 Asia Pacific
      • 5.10.2.3.1 China
      • 5.10.2.3.2 Japan
    • 5.10.2.4 Latin America
      • 5.10.2.4.1 Brazil
      • 5.10.2.4.2 Mexico
    • 5.10.2.5 Middle East
    • 5.10.2.6 Africa
• 5.11 KEY CONFERENCES & EVENTS IN 2024-2025
• 5.12 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.12.1 REVENUE SHIFT AND REVENUE POCKETS FOR SPEAKING VALVE MANUFACTURERS
• 5.13 KEY STAKEHOLDERS & BUYING CRITERIA
  • 5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.13.2 BUYING CRITERIA
• 5.14 INVESTMENT & FUNDING SCENARIO
• 5.15 CASE STUDY ANALYSIS
  • 5.15.1 CASE STUDY: SPEAKING VALVE IMPROVES QUALITY OF LIFE FOR TRACHEOSTOMY PATIENT
• 5.16 IMPACT OF ARTIFICIAL INTELLIGENCE ON SPEAKING VALVES MARKET

6 SPEAKING VALVES MARKET, BY MATERIAL

• 6.1 INTRODUCTION
• 6.2 SILICONE
  • 6.2.1 BIOCOMPATIBLE ADVANTAGE OF SILICONE FOR IMPROVED SPEAKING VALVE PERFORMANCE TO BOOST MARKET GROWTH
• 6.3 PVC
  • 6.3.1 LOW COST OF PVC TO SUPPORT MARKET ADOPTION
• 6.4 OTHER MATERIALS

7 SPEAKING VALVES MARKET, BY APPLICATION

• 7.1 INTRODUCTION
• 7.2 TRACHEOSTOMY
  • 7.2.1 INCREASING NUMBER OF TRACHEOSTOMY PROCEDURES PERFORMED TO DRIVE MARKET GROWTH
• 7.3 LARYNGECTOMY
  • 7.3.1 GROWING ROLE OF SPEAKING VALVES IN LARYNGECTOMY RECOVERY TO SUPPORT GROWTH
• 7.4 OTHER APPLICATIONS

8 SPEAKING VALVES MARKET, BY END USER

• 8.1 INTRODUCTION
• 8.2 HOSPITALS
  • 8.2.1 GROWING NUMBER OF HOSPITALS WORLDWIDE TO BOOST GROWTH
• 8.3 AMBULATORY SURGICAL CENTERS
  • 8.3.1 COST-EFFECTIVENESS OF AMBULATORY SURGICAL CENTERS COMPARED TO HOSPITAL SETTINGS TO FAVOR GROWTH
• 8.4 OTHER END USERS

9 SPEAKING VALVES MARKET, BY REGION

• 9.1 INTRODUCTION
• 9.2 NORTH AMERICA
  • 9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 9.2.2 US
    • 9.2.2.1 US to dominate market in North America during forecast period
  • 9.2.3 CANADA
    • 9.2.3.1 Favorable government investments to augment market growth
• 9.3 EUROPE
  • 9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 9.3.2 GERMANY
    • 9.3.2.1 Germany to command largest share of speaking valves market in Europe
  • 9.3.3 UK
    • 9.3.3.1 Increasing government initiatives and support to aid market
  • 9.3.4 FRANCE
    • 9.3.4.1 Favorable health insurance system to drive market growth
  • 9.3.5 ITALY
    • 9.3.5.1 Well-established healthcare infrastructure to support market
  • 9.3.6 SPAIN
    • 9.3.6.1 Increasing incidence of COPD to fuel market growth
  • 9.3.7 REST OF EUROPE
• 9.4 ASIA PACIFIC
  • 9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 9.4.2 CHINA
    • 9.4.2.1 Large patient population and healthcare infrastructure improvements to drive market growth in China
  • 9.4.3 JAPAN
    • 9.4.3.1 Favorable reimbursement policies and supportive regulatory environment to aid market
  • 9.4.4 INDIA
    • 9.4.4.1 Availability of skilled personnel and low treatment costs to favor market growth
  • 9.4.5 REST OF ASIA PACIFIC
• 9.5 LATIN AMERICA
  • 9.5.1 INCREASING GERIATRIC POPULATION TO PROPEL MARKET
  • 9.5.2 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
• 9.6 MIDDLE EAST & AFRICA
  • 9.6.1 INFRASTRUCTURAL IMPROVEMENTS TO CONTRIBUTE TO MARKET GROWTH
  • 9.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA

10 COMPETITIVE LANDSCAPE

• 10.1 INTRODUCTION
• 10.2 KEY PLAYER STRATEGY/RIGHT TO WIN
  • 10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN SPEAKING VALVES MARKET
• 10.3 REVENUE ANALYSIS
• 10.4 MARKET SHARE ANALYSIS
• 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
  • 10.5.1 STARS
  • 10.5.2 EMERGING LEADERS
  • 10.5.3 PERVASIVE PLAYERS
  • 10.5.4 PARTICIPANTS
  • 10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
    • 10.5.5.1 Company footprint
    • 10.5.5.2 Material footprint
    • 10.5.5.3 Application footprint
    • 10.5.5.4 Region footprint
• 10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
  • 10.6.1 PROGRESSIVE COMPANIES
  • 10.6.2 RESPONSIVE COMPANIES
  • 10.6.3 DYNAMIC COMPANIES
  • 10.6.4 STARTING BLOCKS
  • 10.6.5 COMPETITIVE BENCHMARKING: STARTUP/SME PLAYERS, 2023
• 10.7 COMPANY VALUATION & FINANCIAL METRICS
• 10.8 BRAND/PRODUCT COMPARISON
  • 10.8.1 MEDTRONIC
  • 10.8.2 PASSY-MUIR, INC.
  • 10.8.3 FREUDENBERG GROUP
• 10.9 COMPETITIVE SCENARIO
  • 10.9.1 PRODUCT LAUNCHES
  • 10.9.2 DEALS

11 COMPANY PROFILES

• 11.1 KEY PLAYERS
  • 11.1.1 COLOPLAST A/S
    • 11.1.1.1 Business overview
    • 11.1.1.2 Products offered
    • 11.1.1.3 Recent developments
      • 11.1.1.3.1 Deals
    • 11.1.1.4 MnM view
      • 11.1.1.4.1 Right to win
      • 11.1.1.4.2 Strategic choices
      • 11.1.1.4.3 Weaknesses & competitive threats
  • 11.1.2 FREUDENBERG GROUP
    • 11.1.2.1 Business overview
    • 11.1.2.2 Products offered
    • 11.1.2.3 Recent developments
      • 11.1.2.3.1 Product launches
    • 11.1.2.4 MnM view
      • 11.1.2.4.1 Right to win
      • 11.1.2.4.2 Strategic choices
      • 11.1.2.4.3 Weaknesses & competitive threats
  • 11.1.3 PASSY-MUIR, INC.
    • 11.1.3.1 Business overview
    • 11.1.3.2 Products offered
    • 11.1.3.3 MnM view
      • 11.1.3.3.1 Right to win
      • 11.1.3.3.2 Strategic choices
      • 11.1.3.3.3 Weaknesses & competitive threats
  • 11.1.4 PRIMED HALBERSTADT MEDIZINTECHNIK GMBH
    • 11.1.4.1 Business overview
    • 11.1.4.2 Products offered
  • 11.1.5 MEDTRONIC
    • 11.1.5.1 Business overview
    • 11.1.5.2 Products offered
  • 11.1.6 TELEFLEX INCORPORATED
    • 11.1.6.1 Business overview
    • 11.1.6.2 Products offered
  • 11.1.7 ANDREAS FAHL MEDIZINTECHNIK-VERTRIEB GMBH
    • 11.1.7.1 Business overview
    • 11.1.7.2 Products offered
  • 11.1.8 BOSTON MEDICAL PRODUCTS INC.
    • 11.1.8.1 Business overview
    • 11.1.8.2 Products offered
  • 11.1.9 PEPPER MEDICAL
    • 11.1.9.1 Business overview
    • 11.1.9.2 Products offered
  • 11.1.10 PARBURCH MEDICAL DEVELOPMENTS LTD.
    • 11.1.10.1 Business overview
    • 11.1.10.2 Products offered
• 11.2 OTHER PLAYERS
  • 11.2.1 THE AIRWAY COMPANY
  • 11.2.2 BESMED HEALTH BUSINESS CORP.
  • 11.2.3 PRUNUS MEDICAL
  • 11.2.4 MEDNOM
  • 11.2.5 INSIGHT MEDICAL PRODUCTS LTD.
  • 11.2.6 E. BENSON HOOD LABORATORIES, INC.
  • 11.2.7 ASHTON INDIA PRIVATE LIMITED

12 APPENDIX

• 12.1 DISCUSSION GUIDE
• 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 12.3 CUSTOMIZATION OPTIONS
• 12.4 RELATED REPORTS
• 12.5 AUTHOR DETAILS